Activation by histamine of bronchial epithelial cells from nonasthmatic subjects.
Histamine is a major mediator of the mast cells that are present between epithelial cells in asthma. In asthma, there is an increased expression of ICAM-1 and HLA-DR and an increased spontaneous release of fibronectin. The effect of histamine was tested on bronchial epithelial cells obtained by bronchial brushing from 22 nonasthmatic subjects. The activation of epithelial cells was assessed by immunocytochemical analysis of the expression of membrane markers (ICAM-1 and HLA-DR) using the alkaline phosphatase-anti-alkaline phosphatase method and the release of fibronectin (enzyme immunoassay). Time-response (three experiments) and dose-response (six experiments) curves showed that the maximal effect was obtained after an incubation time of 24 h and a dose of 1 microM of histamine. For this time course and concentration, there was a highly significant increase in the number of cells expressing ICAM-1 (before histamine: 10 +/- 11%; after histamine: 32 +/- 20%; P < 0.001) and HLA-DR (before histamine: 8 +/- 7%; after histamine: 23 +/- 20%; P < 0.001) and in the release of fibronectin (before histamine: 30 +/- 20 ng/10(5) viable cells; after histamine: 61 +/- 35 ng/10(5) viable cells; P < 0.003). Cycloheximide blocked these effects, suggesting that histamine requires protein synthesis for its action. Pyrilamine (H1-blocker) and ranitidine (H2-blocker) at a concentration of 10 microM decreased the effect of histamine. However, there was no additive effect when both antagonists were added. This study suggests that mast cells present in the airways have a role in the activation of epithelial cells.
Vignola
A M
AM
Clinique des Maladies Respiratoires and CJF 92-10 INSERM, Hopital Arnaud de Villeneuve, Montpellier, France.
Campbell
A M
AM
Chanez
P
P
Lacoste
P
P
Michel
F B
FB
Godard
P
P
Bousquet
J
J
D000328:Adult; D000469:Alkaline Phosphatase / Q000378:metabolism; D001249:Asthma / Q000378:metabolism; D001980:Bronchi / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D015815:Cell Adhesion Molecules / Q000378:metabolism; D002478:Cells, Cultured; D003513:Cycloheximide / Q000494:pharmacology; D005353:Fibronectins / Q000378:metabolism; D006684:HLA-DR Antigens / Q000378:metabolism; D006632:Histamine / Q000494:pharmacology*; D006801:Humans; D007150:Immunohistochemistry; D018799:Intercellular Adhesion Molecule-1; D008407:Mast Cells / Q000378:metabolism; D008875:Middle Aged
D015815:Cell Adhesion Molecules; D005353:Fibronectins; D006684:HLA-DR Antigens; D018799:Intercellular Adhesion Molecule-1; D006632:Histamine; D003513:Cycloheximide; D000469:Alkaline Phosphatase